SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012112
Filing Date
2018-05-09
Accepted
2018-05-09 07:22:58
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20180331.htm 10-Q 1255472
2 EX-10.2 acor-ex102_42.htm EX-10.2 106693
3 EX-31.1 acor-ex311_8.htm EX-31.1 16238
4 EX-31.2 acor-ex312_9.htm EX-31.2 15763
5 EX-32.1 acor-ex321_6.htm EX-32.1 6686
6 EX-32.2 acor-ex322_7.htm EX-32.2 6904
7 GRAPHIC g201805090310283772620.jpg GRAPHIC 83315
8 GRAPHIC g201805090310283652619.jpg GRAPHIC 53634
  Complete submission text file 0001564590-18-012112.txt   5925356

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acor-20180331.xml EX-101.INS 1393033
10 XBRL TAXONOMY EXTENSION SCHEMA acor-20180331.xsd EX-101.SCH 36831
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20180331_cal.xml EX-101.CAL 49127
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20180331_def.xml EX-101.DEF 97766
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20180331_lab.xml EX-101.LAB 304578
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20180331_pre.xml EX-101.PRE 240607
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 18816667
SIC: 2836 Biological Products, (No Diagnostic Substances)